Gastric dysregulation induced by microinjection of 6-OHDA in the substantia nigra pars compacta of rats is determined by alterations in the brain-gut axis

American Journal of Physiology - Gastrointestinal and Liver Physiology

Volumn 307, Issue 10, 2014, Pages G1013-G1023

  Toti, Luca ^a   Travagli, R Alberto ^a  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

Author keywords

Brainstem; Gastric motility; Immunohistochemistry; Parkinson s disease

Indexed keywords

CHOLINE ACETYLTRANSFERASE; DOPAMINE BETA MONOOXYGENASE; NEURONAL NITRIC OXIDE SYNTHASE; OXIDOPAMINE; PROTIRELIN; TYRAMINE; TYROSINE 3 MONOOXYGENASE; ADRENERGIC RECEPTOR STIMULATING AGENT; BIOLOGICAL MARKER; DOPAMINE RECEPTOR BLOCKING AGENT; NOS1 PROTEIN, RAT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN STEM; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; GASTRIC DYSMOTILITY; IMMUNOREACTIVITY; MALE; MICROINJECTION; MYENTERIC PLEXUS; NERVE CELL DEGENERATION; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; RAT; STOMACH EMPTYING; SUBSTANTIA NIGRA PARS COMPACTA; ANIMAL; CHEMICALLY INDUCED; DISEASE MODEL; DRUG EFFECTS; INNERVATION; METABOLISM; PARKINSONISM; PATHOPHYSIOLOGY; SPRAGUE DAWLEY RAT; STOMACH; STOMACH PARESIS; SUBSTANTIA NIGRA; TIME;

ANIMALS; BIOLOGICAL MARKERS; CHOLINE O-ACETYLTRANSFERASE; DISEASE MODELS, ANIMAL; DOPAMINE ANTAGONISTS; DOPAMINE BETA-HYDROXYLASE; DOPAMINERGIC NEURONS; GASTRIC EMPTYING; GASTROPARESIS; MALE; MICROINJECTIONS; MYENTERIC PLEXUS; NITRIC OXIDE SYNTHASE TYPE I; OXIDOPAMINE; PARKINSONIAN DISORDERS; PHENOTYPE; RATS, SPRAGUE-DAWLEY; STOMACH; SUBSTANTIA NIGRA; SYMPATHOMIMETICS; TIME FACTORS; TYROSINE 3-MONOOXYGENASE;

EID: 84922394304     PISSN: 01931857     EISSN: 15221547     Source Type: Journal    
DOI: 10.1152/ajpgi.00258.2014     Document Type: Article

References (61)

1. Altschuler SM, Bao X, Bieger D, Hopkins DA, Miselis RR. Viscerotopic representation of the upper alimentary tract in the rat: sensory ganglia and nuclei of the solitary and spinal trigeminal tracts. J Comp Neurol 283: 248-268, 1989.
2. Andresen MC, Kunze DL. Nucleus tractus solitarius- gateway to neural circulatory control. Annu Rev Physiol 56: 93-116, 1994.
3. Annerino DM, Arshad S, Taylor GM, Adler CH, Beach TG, Greene JG. Parkinson's disease is not associated with gastrointestinal myenteric ganglion neuron loss. Acta Neuropathol (Berl) 124: 665-680, 2012.
4. Blandini F, Balestra B, Levandis G, Cervio M, Greco R, Tassorelli C, Colucci M, Faniglione M, Bazzini E, Nappi G, Clavenzani P, Vigneri S, De Giorgio R, Tonini M. Functional and neurochemical changes of the gastrointestinal tract in a rodent model of Parkinson's disease. Neurosci Lett 467: 203-207, 2009.
5. Blessing WW. The Lower Brainstem and Bodily Homeostasis. Oxford, UK: Oxford University Press, 1997.
6. Braak H, Braak E. Pathoanatomy of Parkinson's disease. J Neurol 247, Suppl 2: II3-II10, 2000.
7. Braak H, Rub U, Gai WP, Del Tredici K. Idiopathic Parkinson's disease: possible routes by which vulnerable neuronal types may be subject to neuroinvasion by an unknown pathogen. J Neural Transm 110: 517-536, 2003.
8. Browning KN, Babic T, Holmes GM, Swartz EM, Travagli RA. A critical re-evaluation of the specificity of action of perivagal capsaicin. J Physiol 591: 1563-1580, 2013.
9. Cersosimo MG, Benarroch EE. Neural control of the gastrointestinal tract: Implications for Parkinson disease. Mov Disord 23: 1065-1075, 2008.
10. Cersosimo MG, Benarroch EE. Autonomic involvement in Parkinson's disease: pathology, pathophysiology, clinical features and possible peripheral biomarkers. J Neurol Sci 313: 57-63, 2012.
11. Chang HY, Mashimo H, Goyal RK. Musings on the wanderer: What's new in our understanding of vago-vagal reflex?: IV. Current concepts of vagal efferent projections to the gut. Am J Physiol Gastrointest Liver Physiol 284: G357-G366, 2003.
12. Colucci M, Cervio M, Faniglione M, De AS, Pajoro M, Levandis G, Tassorelli C, Blandini F, Feletti F, De Giorgio R, Dellabianca A, Tonini S, Tonini M. Intestinal dysmotility and enteric neurochemical changes in a Parkinson's disease rat model. Auton Neurosci 169: 77-86, 2012.
13. Costa M, Furness JB, Gibbins IL. Chemical coding of enteric neurons. Prog Brain Res 68: 217-239, 1986.
14. Derkinderen P, Rouaud T, Lebouvier T, Bruley D, V, Neunlist M, De GR. Parkinson disease: the enteric nervous system spills its guts. Neurology 77: 1761-1767, 2011.
15. Drolet RE, Cannon JR, Montero L, Greenamyre JT. Chronic rotenone exposure reproduces Parkinson's disease gastrointestinal neuropathology. Neurobiol Dis 36: 96-102, 2009.
16. Fukuda A, Minami T, Nabekura J, Oomura Y. The effects of noradrenaline on neurones in the rat dorsal motor nucleus of the vagus, in vitro. J Physiol 393: 213-231, 1987.
17. Furness JB. Types of neurons in the enteric nervous system. J Auton Nerv Syst 81: 87-96, 2000.
18. Goedert M, Spillantini MG, Del TK, Braak H. 100 years of Lewy pathology. Nat Rev Neurol 9: 13-24, 2013.
19. Goetze O, Nikodem AB, Wiezcorek J, Banasch M, Przuntek H, Mueller T, Schmidt WE, Woitalla D. Predictors of gastric emptying in Parkinson's disease. Neurogastroenterol Motil 18: 369-375, 2006.
20. Goldstein DS, Sewell L, Sharabi Y. Autonomic dysfunction in PD: a window to early detection? J Neurol Sci 310: 118-122, 2011.
21. Goyal RK, Paterson WG. Esophageal motility. In: Handbook of Physiology. The Gastrointestinal System. The Alimentary Canal. Bethesda, MD: Am. Physiol. Soc., 1989, sect. 6, vol. II, p. 865-908.
22. Grinberg LT, Rueb U, Alho AT, Heinsen H. Brainstem pathology and non-motor symptoms in PD. J Neurol Sci 289: 81-88, 2010.
23. Hawkes CH, Del TK, Braak H. A timeline for Parkinson's disease. Parkinsonism Relat Disord 16: 79-84, 2010.
24. Herman MA, Niedringhaus M, Alayan A, Verbalis JG, Sahibzada N, Gillis RA. Characterization of noradrenergic transmission at the Dorsal Motor Nucleus of the Vagus involved in reflex control of fundus tone. Am J Physiol Regul Integr Comp Physiol 294: R720-R729, 2008.
25. Jean A. Brainstem control of swallowing: neuronal network and cellular mechanisms. Physiol Rev 81: 929-969, 2001.
26. Jellinger KA. Synuclein deposition and non-motor symptoms in Parkinson disease. J Neurol Sci 310: 107-111, 2011.
27. Jost WH. Gastrointestinal dysfunction in Parkinson's Disease. J Neurol Sci 289: 69-73, 2010.
28. Kaneoke Y, Koike Y, Sakurai N, Washimi Y, Hirayama M, Hoshiyama M, Takahashi A. Gastrointestinal dysfunction in Parkinson's disease detected by electrogastroenterography. J Auton Nerv Syst 50: 275-281, 1995.
29. Kessler JP, Jean A. Effect of catecholamines on the swallowing reflex after pressure microinjections into the lateral solitary complex of the medulla oblongata. Brain Res 386: 69-77, 1986.
30. Kim JB, Kim BJ, Koh SB, Park KW. Autonomic dysfunction according to disease progression in Parkinson's disease. Parkinsonism Relat Disord 20: 303-307, 2013.
31. Llewellyn-Smith IJ, Kellett DO, Jordan D, Browning KN, Travagli RA. Oxytocin-immunoreactive innervation of identified neurons in the rat dorsal vagal complex. Neurogastroenterol Motil 24: e136-e146, 2012.
32. Martinez-Pena, y Valenzuela IM, Rogers RC, Hermann GE, Travagli RA Norepinephrine effects on identified neurons of the rat dorsal motor nucleus of the vagus. Am J Physiol Gastrointest Liver Physiol 286: G333-G339, 2004.
33. McDowell K, Chesselet MF. Animal models of the non-motor features of Parkinson's disease. Neurobiol Dis 46: 597-606, 2012.
34. Miampamba M, Yang H, Sharkey KA, Tache Y. Intracisternal TRH analog induces Fos expression in gastric myenteric neurons and glia in conscious rats. Am J Physiol Gastrointest Liver Physiol 280: G979-G991, 2001.
35. Moore DJ, West AB, Dawson VL, Dawson TM. Molecular pathophysiology of Parkinson's Disease. Annu Rev Neurosci 28: 57-87, 2005.
36. Nagata M, Osumi Y. Central noradrenergic inhibition of gastric motility in rats. Eur J Pharmacol 223: 153-156, 1992.
37. Nakamura K, Takahashi T, Taniuchi M, Hsu CX, Owyang C. Nicotinic receptor mediates nitric oxide synthase expression in the rat gastric myenteric plexus. J Clin Invest 101: 1479-1489, 1998.
38. Natale G, Pasquali L, Ruggieri S, Paparelli A, Fornai F. Parkinson's disease and the gut: a well known clinical association in need of an effective cure and explanation. Neurogastroenterol Motil 20: 741-749, 2008.
39. Noorian AR, Rha J, Annerino DM, Bernhard D, Taylor GM, Greene JG. Alpha-synuclein transgenic mice display age-related slowing of gastrointestinal motility associated with transgene expression in the vagal system. Neurobiol Dis 48: 9-19, 2012.
40. Palma JA, Kaufmann H. Autonomic disorders predicting Parkinson's disease. Parkinsonism Relat Disord 20, Suppl 1: S94-S98, 2014.
41. Pan-Montojo F, Anichtchik O, Dening Y, Knels L, Pursche S, Jung R, Jackson S, Gille G, Spillantini MG, Reichmann H, Funk RH. Progression of Parkinson's disease pathology is reproduced by intragastric administration of rotenone in mice. PLoS One 5: e8762, 2010.
42. Pfeiffer RF. Gastrointestinal dysfunction in Parkinson's disease. Lancet Neurol 2: 107-116, 2003.
43. Poewe W. Non-motor symptoms in Parkinson's disease. Eur J Neurol 15, Suppl 1: 14-20, 2008.
44. Qualls-Creekmore E, Tong M, Holmes GM. Gastric emptying of enterally administered liquid meal in conscious rats and during sustained anaesthesia. Neurogastroenterol Motil 22: 181-185, 2010.
45. Rogers RC, Hermann GE, Travagli RA. Brainstem pathways responsible for oesophageal control of gastric motility and tone in the rat. J Physiol 514: 369-383, 1999.
46. Rogers RC, Travagli RA, Hermann GE. Noradrenergic neurons in the rat solitary nucleus participate in the esophageal-gastric relaxation reflex. Am J Physiol Regul Integr Comp Physiol 285: R479-R489, 2003.
47. Schapira AH. Neurobiology and treatment of Parkinson's disease. Trends Pharmacol Sci 30: 41-47, 2008.
48. Schemann M, Grundy D. Electrophysiological identification of vagally innervated enteric neurons in guinea pig stomach. Am J Physiol Gastrointest Liver Physiol 263: G709-G718, 1992.
49. Soykan I, Lin Z, Bennett JP, McCallum RW. Gastric myoelectrical activity in patients with Parkinson's disease: evidence of a primary gastric abnormality. Dig Dis Sci 44: 927-931, 1999.
50. Tache Y, Stephens RL Jr, Ishikawa T. Central nervous system action of TRH to influence gastrointestinal function and ulceration. Ann NY Acad Sci 553: 269-285, 1989.
51. Tian YM, Chen X, Luo DZ, Zhang XH, Xue H, Zheng LF, Yang N, Wang XM, Zhu JX. Alteration of dopaminergic markers in gastrointestinal tract of different rodent models of Parkinson's disease. Neuroscience 153: 634-644, 2008.
52. Toti L, Travagli RA. A nigro-vagal pathway controls gastric motility. Digestive Disease Week. Chicago, IL: May 3-6, 2014.
53. Travagli RA, Gillis RA, Vicini S. Effects of thyrotropin-releasing hormone on neurons in rat dorsal motor nucleus of the vagus, in vitro. Am J Physiol Gastrointest Liver Physiol 263: G508-G517, 1992.
54. Travagli RA, Hermann GE, Browning KN, Rogers RC. Brainstem circuits regulating gastric function. Annu Rev Physiol 68: 279-305, 2006.
55. Wakabayashi K, Takahashi H, Takeda S, Ohama E, Ikuta F. Parkinson's disease: the presence of Lewy bodies in Auerbach's and Meissner's plexuses. Acta Neuropathol (Berl) 76: 217-221, 1988.
56. Wang L, Mogami S, Karasawa H, Yamada C, Yakabi S, Yakabi K, Hattori T, Tache Y. Preventive effect of rikkunshito on gastric motor function inhibited by L-dopa in rats. Peptides 55: 136-144, 2014.
57. Zheng LF, Song J, Fan RF, Chen CL, Ren QZ, Zhang XL, Feng XY, Zhang Y, Li LS, Zhu JX. The role of the vagal pathway and gastric dopamine in the gastroparesis of rats after a 6-hydroxydopamine microinjection in the substantia nigra. Acta Physiol (Oxf) 211: 434-446, 2014.
58. Zheng LF, Wang ZY, Li XF, Song J, Hong F, Lian H, Wang Q, Feng XY, Tang YY, Zhang Y, Zhu JX. Reduced expression of choline acetyltransferase in vagal motoneurons and gastric motor dysfunction in a 6-OHDA rat model of Parkinson's disease. Brain Res 1420: 59-67, 2011.
59. Zheng LF, Zhang Y, Chen CL, Song J, Fan RF, Cai QQ, Wang ZY, Zhu JX. Alterations in TH- and ChAT-immunoreactive neurons in the DMV and gastric dysmotility in an LPS-induced PD rat model. Auton Neurosci 177: 194-198, 2013.
60. Zheng Z, Travagli RA. Dopamine effects on identified rat vagal motoneurons. Am J Physiol Gastrointest Liver Physiol 292: G1002-G1008, 2007.
61. Zhu HC, Zhao J, Luo CY, Li QQ. Gastrointestinal dysfunction in a Parkinson's disease rat model and the changes of dopaminergic, nitric oxidergic, and cholinergic neurotransmitters in myenteric plexus. J Mol Neurosci 47: 15-25, 2012.